Fungi Bioactive Metabolites Integration of Pharmaceutical Applications
This book presents the exploration and exploitation of various bioactive metabolites obtained from fungi isolated from diverse habitats for pharmaceutical applications. Various fungal sources have been brought under one umbrella ranging from endophytes, marine fungi, endolichenic fungi to fungi exis...
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Singapore
Springer Nature Singapore
2024, 2024
|
| Edition: | 1st ed. 2024 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Part I: Bioactive Compounds from Endophytic Fungi
- Chapter 1. Recent Advances in Pharmaceutically Important Compounds from Endophytic Fungi
- Chapter 2. Pharmaceutically Important Compound Produced by Endophytic Fungi Having Anti-Infective Activity
- Chapter 3. Fungal Endophytes: An Accessible Natural Repository for Discovery of Bioactive Compounds
- Part II: Endolichenic Fungi: A Source of New Chemical Entities
- Chapter 4. Endolichenic Fungi as a Source of Pharmaceutically Active Compounds
- Chapter 5. Endolichenic Fungi, an Emerging Source of Bioactive Compounds: A Pharmaceutical Perspective
- Part III: Marine Fungi as a Source of Medicinal Compounds
- Chapter 6. Antibiofilm Metabolites from Sponge-derived Aspergillus, Penicillium, and Fusarium for the Antibiotic Pipeline
- Chapter 7. Marine Fungi as a Bioresource of Medicinal Entities
- Chapter 24. How Does Bioinformatics Play a Role in Fungal Drug Discovery?
- Chapter 25. Fungal Biotransformation of Steroids: History, Current Status, and Future Prospects.
- Chapter 16. Uncovering the Desert Fungal Enigma: An Attractive Resource for Biopharmaceuticals
- Chapter 17. Bioactive Metabolites Produced by Fungi Present inAntarctic, Arctic and Alpine Ecosystems
- Part VI: Novel Strategies to Screen or Enhance Secondary Metabolite Production
- Chapter 18. Enhancing Chemical Diversity of Fungal Secondary Metabolite by OSMAC Strategy
- Chapter 19. Epigenetic Regulation of Fungal Secondary Metabolites for the Enhancement of Therapeutically Active Compounds
- Chapter 20. Strategies for Enhancing the Production of Echinocandin
- Part VII: Other by Products of Fungal Metabolism with Medicinal Applications
- Chapter 21. Fungal Pigments: Applications and Their Medicinal Potential
- Chapter 22. A Brief Insight into Peptide and Non-Peptide Drugs of Fungal Origin
- Chapter 23. Kojic Acid from Aspergillus wentii: A Journey from Isolation to Application
- Part VIII: Bioinformatics and Fungal Biotransformations in Pharmaceutical Drug Development
- Chapter 8. Natural Bioactive Products from Marine Fungi against Bacterial Infection. Part IV: Fungi as a Bioresource of Pharmacologically Active Agents
- Chapter 9. Penicillium: A Treasure-Trove for Antimycobacterial and Antioxidant Metabolites
- Chapter 10. Metabolites from Fungi: a Promising Source of Lead Compounds against Cancer
- Chapter 11. Edible Mushrooms Substances as Natural Prevention in Autoimmunological Diseases
- Chapter 12. New Antifungal Drugs: Discovery and Therapeutic Potential
- Chapter 13. Fungal Enzyme Inhibitors: Potent Repository of Lead Compounds to Curb Cancer
- Chapter 14. Bioactive Metabolites from Fungi with Anti-Inflammatory and Anti-Thrombotic Properties; Current Status and Future Perspectives for Drug Development
- Chapter 15. Progress in the Development of Fungal Metabolites as New Drugs for Human Mycoses
- Part V: Fungi from Extremophilic Environment/Unique Ecosystems